Q4 2021 13F Holders as of 31 Dec 2021
-
Type / Class
-
Debt / NOTE 1.250% 5/1
-
Market price (% of par)
-
104.31%
-
Total 13F principal
-
$217,348,919
-
Principal change
-
-$29,220,796
-
Total reported market value
-
$227,106,951
-
Number of holders
-
32
-
Value change
-
-$32,276,030
-
Number of buys
-
15
-
Number of sells
-
11
Institutional Holders of BIOMARIN PHARMACEUTICAL INC - NOTE 1.250% 5/1 as of Q4 2021
As of 31 Dec 2021,
BIOMARIN PHARMACEUTICAL INC - NOTE 1.250% 5/1 was held by
32 institutional
bondholders
reporting positions in Form 13F filings.
These institutions reported holding
$217,348,919
in principal (par value) of the bond.
The largest 10 bondholders included
MACKAY SHIELDS LLC, ADVENT CAPITAL MANAGEMENT /DE/, AQR Arbitrage LLC, Thrivent Financial for Lutherans, DZ BANK AG Deutsche Zentral Genossenschafts Bank, Frankfurt am Main, STATE STREET CORP, LAZARD ASSET MANAGEMENT LLC, NEW YORK STATE COMMON RETIREMENT FUND, AVIVA PLC, and BNP PARIBAS ASSET MANAGEMENT Holding S.A..
This page lists
32
institutional bondholders reporting positions
for the Q4 2021 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price (% of par)
|
Principal |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.